Assessment and impact of dose escalation on anti-drug antibodies in Fabry disease by Malte Lenders, Eva Brand

Get full text

In Vitro and In Vivo Amenability to Migalastat in Fabry Disease by Malte Lenders, Franciska Stappers, Eva Brand

Get full text

Pre-existing anti-drug antibodies in Fabry disease show less affinity for pegunigalsidase alfa by Malte Lenders, Solvey Pollmann, Melina Terlinden, Eva Brand

Get full text

Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact? by Malte Lenders, Boris Schmitz, Stefan-Martin Brand, Eva Brand

Get full text

Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation by Solvey Pollmann, David Scharnetzki, Dominique Manikowski, Malte Lenders, Eva Brand

Get full text

Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with Fabry disease by Malte Lenders, Lina Marleen Feidicker, Stefan-Martin Brand, Eva Brand

Get full text

Generation and Characterization of a Polyclonal Human Reference Antibody to Measure Anti-Drug Antibody Titers in Patients with Fabry Disease by Malte Lenders, David Scharnetzki, Ali Heidari, Daniele Di Iorio, Seraphine Valeska Wegner, Eva Brand

Get full text

Complement activation and cellular inflammation in Fabry disease patients despite enzyme replacement therapy by Björn Laffer, Malte Lenders, Elvira Ehlers-Jeske, Karin Heidenreich, Eva Brand, Jörg Köhl, Jörg Köhl

Get full text

CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B. by Michael Pöhler, Sarah Guttmann, Oksana Nadzemova, Malte Lenders, Eva Brand, Andree Zibert, Hartmut H Schmidt, Vanessa Sandfort

Get full text

α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes by Ulrich Jehn, Samet Bayraktar, Solvey Pollmann, Veerle Van Marck, Thomas Weide, Hermann Pavenstädt, Eva Brand, Malte Lenders

Get full text

Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease by Christian Pogoda, Stefan-Martin Brand, Thomas Duning, Thomas Duning, Antje Schmidt-Pogoda, Jürgen Sindermann, Malte Lenders, Eva Brand

Get full text

Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma by Katrin Schelleckes, Boris Schmitz, Giuliano Ciarimboli, Malte Lenders, Hermann J. Pavenstädt, Edwin Herrmann, Stefan-Martin Brand, Eva Brand

Get full text

CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B by Michael Pöhler, Sarah Guttmann, Oksana Nadzemova, Malte Lenders, Eva Brand, Andree Zibert, Hartmut H. Schmidt, Vanessa Sandfort, Oleg Y. Dmitriev

Get full text

Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease by Sanne J. van der Veen, Wytze J. Vlietstra, Laura van Dussen, André B.P. van Kuilenburg, Marcel G. W. Dijkgraaf, Malte Lenders, Eva Brand, Christoph Wanner, Derralynn Hughes, Perry M. Elliott, Carla E. M. Hollak, Mirjam Langeveld

Get full text